Search

Amyotrophic lateral sclerosis (ALS) also known as Lou Gehrig’s Disease, is a neurodegenerative disease for which there is no effective treatment. Project Overview Amyotrophic lateral sclerosis (ALS) also known as Lou Gehrig’s Disease, is a neurodegenerative disease for which there is no effective...

We need new ways to treat Alzheimer’s Disease (AD). People with AD are keen to try non-drug therapies but none are approved for treating AD. Remote ischemic conditioning (RIC) is a non-drug therapy that involves inflating and deflating blood pressure cuffs repeatedly in the arm or leg. Project...

In Multiple Sclerosis (MS), new brain lesions appear because of inflammation and loss of myelin (the structure covering nerves). Project Overview In Multiple Sclerosis (MS), new brain lesions appear because of inflammation and loss of myelin (the structure covering nerves). MS treatments stop...

RATIONALE: There are no effective disease modifying therapies for amyotrophic lateral sclerosis (ALS). Project Overview RATIONALE: There are no effective disease modifying therapies for amyotrophic lateral sclerosis (ALS). Complete understanding of the physiopathology of ALS is lacking, and...

The loss of connections between nerve cells is an early indicator of Alzheimer’s disease. Project Overview The loss of connections between nerve cells is an early indicator of Alzheimer’s disease. The loss of these connections also causes difficulty thinking and processing information....

Our ability to learn is directly proportional to our ability to detect the difference between a prediction and its outcome. Project Overview Our ability to learn is directly proportional to our ability to detect the difference between a prediction and its outcome. Reinforcement learning theories,...

Meet the junior researchers behind the 2022 ALS Canada – Brain Canada Trainee Awards. Dr. Hussein Ghazale is the recipient of a $165,000 ALS Canada – Brain Canada 2022 Trainee Award. Meet the junior researchers behind the 2022 ALS Canada – Brain Canada Trainee Awards Dr. Hussein Ghazale is the...

For many people living with treatment-resistant depression – whose symptoms have not improved with antidepressant medications or psychotherapy – repetitive transcranial magnetic stimulation (rTMS) can be life-changing. Some describe it as a fog finally being lifted. Some say it’s like their eyes...

Brain Canada and Heart & Stroke are pleased to officially launch the Heart-Brain Connection IMPACT Award, a multi-disciplinary, multi-institutional, integrative research competition that will investigate the complex interactions between the heart and the brain by leveraging the power of...

Brain Canada and JDRF are pleased to officially launch the JDRF Canada – Brain Canada Addressing Mental Health in Type 1 Diabetes Team Grants, a program to support research on the development, validation, or implementation of interventions that address mental health concerns in people with type 1...